BSO recalls

BSO has 5 recalls on record with the FDA and USDA, the earliest in 2025 and the latest reported on 14 May 2025. 5 are still ongoing. The most frequent reason is particulate matter.

Total recalls5since 2025

Last 12 months0reported

Class I00% of total

Ongoing5latest 14 May 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 5 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 5 100%Class III 0 0%

Why bso is recalled

Particulate Matter5100%

Product types

Hormones & Birth Control5100%

By year

20255100%

Ongoing bso recalls

5 active

Reported	Class	Recall	Company	Reason	Where
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg (with Cholesterol </=2%) recalled by BSO	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg Blunt (with Cholesterol </=2%) recalled	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg (with Cholesterol </=4%) recalled by BSO	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg Blunt, 1 Pellet recalled by BSO	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 100 mg (with Cholesterol </=4%) recalled by BSO	BSO	Particulate Matter	Nationwide

All bso recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg (with Cholesterol </=2%) recalled by BSO	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg Blunt (with Cholesterol </=2%) recalled	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg (with Cholesterol </=4%) recalled by BSO	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 200 mg Blunt, 1 Pellet recalled by BSO	BSO	Particulate Matter	Nationwide
14 May 2025Drug	CLASS II	Testosterone Pellet 100 mg (with Cholesterol </=4%) recalled by BSO	BSO	Particulate Matter	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.